A distinct CAR-T cell phenotype mediates therapeutic response at limited doses. [PDF]
Yousefian S +19 more
europepmc +1 more source
Synergistic Cancer Immunotherapy by Inducing Immunogenic Cell Death and Blocking the CD39-Adenosine Pathway Using a Nanoplatform. [PDF]
Liu Y +5 more
europepmc +1 more source
AC3<sup>®</sup> exerts cytotoxic and anti-migratory activity and modulates the gene expression of TNF-α, inflammatory mediators, and components of the CD39/CD73/adenosine axis in cutaneous melanoma cell lines. [PDF]
Manica D +11 more
europepmc +1 more source
Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sézary syndrome. [PDF]
Marchisio S +14 more
europepmc +1 more source
CD39 mRNA therapy attenuates localized acute inflammation: A novel anti-inflammatory strategy using cationic nanoliposomes. [PDF]
Philosof NR +16 more
europepmc +1 more source
Calcitriol, the active form of vitamin D, induces cell death and purinergic signaling modulation in cutaneous melanoma cells. [PDF]
da Silva GB +7 more
europepmc +1 more source
Immune checkpoint crosstalk between LAG-3 and CD39/CD73 in glioblastoma: dual-pathway regulation of metabolic exhaustion and therapeutic reversal strategies. [PDF]
Mukherjee A.
europepmc +1 more source
Intratumoral enrichment and suppressive activity of DP8α regulatory T cells in human colorectal cancer. [PDF]
Deiber M +7 more
europepmc +1 more source
Exercise as a modulator of purinergic signaling and inflammation in cancer-associated sarcopenia: a narrative review. [PDF]
de Oliveira EM +4 more
europepmc +1 more source
Apremilast therapy increases CD39<sup>+</sup>CD4<sup>+</sup> T cells in peripheral blood of patients with psoriatic disease: a retrospective observational pilot study. [PDF]
Mavropoulos A +6 more
europepmc +1 more source

